Where Two Common Conditions of Aging Meet: Osteoarthritis and Sarcopenia.


Journal

Calcified tissue international
ISSN: 1432-0827
Titre abrégé: Calcif Tissue Int
Pays: United States
ID NLM: 7905481

Informations de publication

Date de publication:
09 2020
Historique:
received: 27 01 2020
accepted: 12 05 2020
pubmed: 20 5 2020
medline: 15 7 2021
entrez: 20 5 2020
Statut: ppublish

Résumé

Osteoarthritis and sarcopenia are the most frequently described musculoskeletal disorders in older persons but the intertwining of these conditions and of their functional and cellular causes is complex. This narrative review aims to identify the links between osteoarthritis and sarcopenia described 1-in clinical studies, 2-in in vitro studies, and 3-the available treatment strategies for both conditions. Electronic databases were used for the literature search of all studies investigating the relationship between sarcopenia and the presence of concomitant osteoarthritis. This review identified a limited number of clinical and morphometric studies on the complex relationship between osteoarthritis and sarcopenia. Studies present a number of methodological limitations due to definition and assessment of both entities. Low lean mass is one of the main actors of this cross-talk between muscle and bone, and adipose tissue plays a major role that had been underestimated. Bone Morphogenetic Proteins and myostatin pathways are key mediators and play an important role in both muscle and bone homeostasis. Common therapeutic recommendations are still missing. There is a need for good quality prospective studies on concomitant sarcopenia and osteoarthritis, more translational research, and pharmacological and non-pharmacological therapies in order to identify common denominators for the management of sarcopenia, osteoarthritis, and their comorbidities.

Identifiants

pubmed: 32424600
doi: 10.1007/s00223-020-00703-5
pii: 10.1007/s00223-020-00703-5
doi:

Substances chimiques

Bone Morphogenetic Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

203-211

Auteurs

Marie-Eva Pickering (ME)

Service de Rhumatologie et Pathologie Osseuse, Hôpital Edouard Herriot, 69437, Lyon cedex 03, France. marie-eva.pickering@hotmail.fr.
Inserm UMR 1033, 69437, Lyon cedex 03, France. marie-eva.pickering@hotmail.fr.
Université de Lyon, 69437, Lyon cedex 03, France. marie-eva.pickering@hotmail.fr.

Roland Chapurlat (R)

Service de Rhumatologie et Pathologie Osseuse, Hôpital Edouard Herriot, 69437, Lyon cedex 03, France.
Inserm UMR 1033, 69437, Lyon cedex 03, France.
Université de Lyon, 69437, Lyon cedex 03, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH